Puma Biotechnology CEO Alan Auerbach's 2020 pay rises 18% to $4.4M
Puma Biotechnology reports 2020 executive compensation
By ExecPay News
Published: April 26, 2021
Puma Biotechnology reported fiscal year 2020 executive compensation information on April 26, 2021.
In 2020, five executives at Puma Biotechnology received on average a compensation package of $2.4M, a 36% increase compared to previous year.
Average pay of disclosed executives at Puma Biotechnology
Alan H. Auerbach, Chief Executive Officer, received $4.4M in total, which increased by 18% compared to 2019. 36% of Auerbach's compensation, or $1.6M, was in option awards. Auerbach also received $418K in non-equity incentive plan, $834K in salary, $1.6M in stock awards, as well as $14K in other compensation.
Jeff J. Ludwig, Chief Commercial Officer, received a compensation package of $3.3M. 60% of the compensation package, or $2M, was in option awards.
Richard P. Bryce, B, MRCGP and MFPM Former Chief Medical and Scientific Officer, earned $1.8M in 2020, a 39% increase compared to previous year.
Douglas Hunt, B. Sc Hons, Senior Vice President, Regulatory Affairs, Medical Writing and Project Management, received $1.6M in 2020, which increases by 16% compared to 2019.
Maximo F. Nougues, Chief Financial Officer, earned $979K in 2020, a 47% increase compared to previous year.
Related executives
Alan Auerbach
Puma Biotechnology
Chief Executive Officer
Maximo Nougues
Puma Biotechnology
Chief Financial Officer
Richard Bryce
Puma Biotechnology
B, MRCGP and MFPM Former Chief Medical and Scientific Officer
Jeff Ludwig
Puma Biotechnology
Chief Commercial Officer
Douglas Hons
Puma Biotechnology
Senior Vice President, Regulatory Affairs, Medical Writing and Project Management
You may also like
Source: SEC filing on April 26, 2021.